Drugs / Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02980510 Comparator | Dec 2016 → Dec 2025 | colorectal cancer | UNICANCER | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02980510 ↗ |